SCHEMBL30098521

SCHEMBL30098521

CC(O)c1cccc2cnccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
MAPKAPK2 P49137 1/20 0.55
LMNA P02545 3/20 0.52
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTT P42858 1/20 0.46
MAPT P10636 5/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 2/20 0.42
TRPV1 Q8NER1 5/20 0.41
ADRA2A P08913 4/20 0.41
ADRA2B P18089 4/20 0.41
ADRA2C P18825 4/20 0.41
ADRA1A P35348 4/20 0.41
ADRA1D P25100 3/20 0.41
ADRA1B P35368 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1830567 1.00 KDM4E (0.55) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL14893930 0.86 TNF (0.46) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL14893767 0.86 TNF (0.46) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL14896388 0.86 TNF (0.46) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL2607319 0.85 LMNA (0.53) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL24493538 0.82 LMNA (0.50) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL7231935 0.82 LMNA (0.50) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL22216993 0.82 LMNA (0.50) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL30239333 0.82 CYP3A4 (0.55) KDM4EMAPKAPK2LMNACYP1A2CYP3A4
SCHEMBL28462007 0.82 CYP3A4 (0.55) KDM4EMAPKAPK2LMNACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118878514-A Heterocyclic compounds for modulating NR2F6 TES制药有限责任公司 2024-11-01 CN disclosed
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 WO disclosed
CN-115427394-A Heterocyclic compounds for modulating NR2F6 TES制药有限责任公司 2022-12-02 CN disclosed